RBX1 Antibody, Rabbit, Polyclonal

Catalog Number: NSJ-F54242-0.4ML
Article Name: RBX1 Antibody, Rabbit, Polyclonal
Biozol Catalog Number: NSJ-F54242-0.4ML
Supplier Catalog Number: F54242-0.4ML
Alternative Catalog Number: NSJ-F54242-0.4ML
Manufacturer: NSJ Bioreagents
Host: Rabbit
Category: Antikörper
Application: IF, IHC-P, WB
Species Reactivity: Human, Mouse
Immunogen: A portion of amino acids 78-108 from the human protein were used as the immunogen for the RBX1 antibody.
E3 ubiquitin ligase component of multiple cullin-RING- based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins, including proteins involved in cell cycle progression, signal transduction, transcription and transcription-coupled nucleotide excision repair. The functional specificity of the E3 ubiquitin-protein ligase complexes depends on the variable substrate recognition components. As a component of the CSA complex promotes the ubiquitination of ERCC6 resulting in proteasomal degradation. Through the RING-type zinc finger, seems to recruit the E2 ubiquitination enzyme, like CDC34, to the complex and brings it into close proximity to the substrate. Probably also stimulates CDC34 autoubiquitination. May be required for histone H3 and histone H4 ubiquitination in response to ultraviolet and for subsequent DNA repair. Promotes the neddylation of CUL1, CUL2, CUL4 and CUL4 via its interaction with UBE2M. Involved in the ubiquitination of KEAP1, ENC1 and KLHL41. In concert with ATF2 and CUL3, promotes degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM.
Clonality: Polyclonal
UniProt: P62877
Purity: Antigen affinity purified
Form: In 1X PBS, pH 7.4, with 0.09% sodium azide
Antibody Type: Primary Antibody
Application Dilute: Western blot: 1:1000,Immunohistochemistry (FFPE): 1:25-1:50,Immunofluorescence: 1:25
Application Notes: The stated application concentrations are suggested starting points. Titration of the RBX1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.